Impathiq is a leading brand that specializes in developing EHR SMART-FHIR applications, with a particular focus on the HEART Pathway. One of their standout products is the High-Sensitivity Troponin, which provides support for clinicians in diagnosing and managing patients with chest pain. Impathiq recognizes that chest pain is a common reason for emergency department visits in the United States, with millions of patients seeking medical attention annually.

To address this issue, Impathiq combines the results of rigorous clinical research studies with human factors engineering to create reliable and efficient systems that enhance clinical decision-making. Impathiq boasts an exceptional team with years of experience and expertise in healthcare and technology. Their team includes professionals such as Mary Hardy, the Chief Executive Officer, and Scott Gilmore, MD, the Co-Founder and President.

Other key members of the team include Simon Mahler, MD, Co-Founder and Chief Medical Officer, and Jameson Holden, PhD, the Chief Technology Officer. Impathiq's mission is to provide clinicians and patients with reliable systems that facilitate important clinical decisions. With their innovative products and a dedicated team, Impathiq is committed to improving healthcare outcomes and transforming the landscape of medical technology.

Contact Impathiq today at 1-833-IMPATHIQ to learn more about their cutting-edge products and services